Filter my results
Search
Displaying 1 - 8 of 8
“The Construction of Lay Expertise: AIDS Activism and the Forging of Credibility in the Reform of Clinical Trials” (1995), by Steven Epstein
By: Jarrett L. Joubert
| Published: Jun 24, 2024
On 1 October 1995, Steven Epstein published “The Construction of Lay Expertise: AIDS Activism and the Forging of Credibility in the Reform of…
HIV SeropositivityAcquired Immunodeficiency SyndromePneumocystis cariniiPneumocystis InfectionsHIV
A Series of YouTube Videos Detailing the “CRISPR Babies” Experiment (2018), by He Jiankui
By: Risa Aria Schnebly, Brianna Ellis
| Published: Jul 31, 2021
In 2018, He Jiankui uploaded a series of videos to a YouTube channel titled “The He Lab” that detailed one of the first instances of a successful…
Literaturegene editingGenome EditingCRISPR (Genetics)CRISPR-associated protein 9
“Knowledge, Attitudes, and Practices of Health Personnel of Maternities in the Prevention of Mother-to-Child Transmission of HIV...” (2018), by Elie Nkwabong, Romuald Meboulou Nguel, Nelly Kamgaing, and Anne Sylvie Keddi Jippe
By: Alexis Darby, Sierra Hope Jones
| Published: Apr 06, 2021
In 2018, researchers Elie Nkwabong, Romuald Meboulou Nguel, Nelly Kamgaing, and Anne Sylvie Keddi Jippe published, “Knowledge, Attitudes, and…
LiteratureHIV-positive womenHIV-positive childrenHIV (Viruses)HIV infections
World Health Organization Guidelines (Option A, B, and B+) for Antiretroviral Drugs to Treat Pregnant Women and Prevent HIV Infection in Infants
By: Sierra Hope Jones, Alexis Darby
| Published: Mar 01, 2021
To address the international Human Immunodeficiency Virus epidemic, the World Health Organization, or WHO, developed three drug treatment regimens…
HIV-positive personsHIV infectionsHIV-positive youthHIV-positive womenHIV-positive children
World Health Organization Guidelines (Option A, B, and B+) for Antiretroviral Drugs to Treat Pregnant Women and Prevent HIV Infection in Infants
By: Sierra Hope Jones, Alexis Darby
| Published: Mar 01, 2021
To address the international Human Immunodeficiency Virus epidemic, the World Health Organization, or WHO, developed three drug treatment regimens…
HIV-positive personsHIV infectionsHIV-positive youthHIV-positive womenHIV-positive children
“Chapter Two: Minimum Initial Services Package (MISP)” in Reproductive Health in Refugee Situations: An Inter-agency Field Manual (1999), by the Inter-Agency Working Group on Reproductive Health in Crises
By: Ross J. Nalubega
| Published: Jan 18, 2021
In 1999, the Inter-agency Working Group on Reproductive Health in Crises, hereafter the IAWG, wrote the Minimum Initial Services Package, hereafter…
LiteratureRefugee campsChildbirthBirthHIV
Ian Hector Frazer (1953– )
By: Alexis Darby
| Published: Sep 02, 2020
Ian Hector Frazer studied the human immune system and vaccines in Brisbane, Australia, and helped invent and patent the scientific process and…
PeopleHIV infectionsHIV-positive personsHIV (Viruses)Vaccines industry
US Regulatory Response to Thalidomide (1950-2000)
By: Chanapa Tantibanchachai
| Published: Apr 01, 2014
Thalidomide, a drug capable of causing fetal abnormalities (teratogen), has caused greater than ten thousand birth defects worldwide since its…
ContextThalidomideThalidomide--Side effectsTeratogenicity testingMultiple Myeloma